27th Nov 2014 11:41
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Bioquell Plc |
2 Reason for the notification (please tick the appropriate box or boxes): | ||
An acquisition or disposal of voting rights | YES | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||
An event changing the breakdown of voting rights | ||
Other (please specify): |
| |
3. Full name of person(s) subject to the notification obligation: iii |
Harwood Capital LLP (as investment manager)
|
4. Full name of shareholder(s) (if different from 3.): iv |
(1) North Atlantic Smaller Companies Investment Trust Plc
(2) Oryx International Growth Fund Limited
3) Harwood Capital LLP (as investment manager to discretionary private clients)
|
5. Date of the transaction and date on which the threshold is crossed or reached: v | 26 November 2014 |
6. Date on which issuer notified: | 27 November 2014 |
7. Threshold(s) that is/are crossed or reached: vi, vii | 29% |
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
GB0004992003
| |||||||
Holder 1 | 9,050,000 | 9,050,000 | 9,500,000 | 9,500,000 | 22.33% | ||
Holder 2 | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | 7.05% | ||
Holder 3 | 110,000 | 110,000 | 110,000 | 110,000 | 0.26% |
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financialinstrument | Expirationdate xiii | Exercise/ConversionPeriod xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted.
| % of votingrights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exerciseprice | Expirationdate xvii | Exercise/Conversionperiod xviii | Number of votingrights instrumentrefers to | % of voting rights xix, xx
| |
Nominal | Delta
| |||||
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
12,610,000 | 29.64% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi |
|
Proxy Voting: | |
10. Name of the proxy holder: | |
11. Number of voting rights proxy holder will cease to hold: | |
12. Date on which proxy holder will cease to hold voting rights: |
13. Additional information: | Number of shares in issue used is 42,535,363 shares |
14. Contact name: | Bonita Guntrip |
15. Contact telephone number: | 020 7640 3203 |
Related Shares:
Bioquell